ORDER OF CERTIFICATION TO THE SUPREME COURT OF OHIO
On remand from this court’s decision in
Planned Parenthood v. Taft,
Because neither side addressed the issue of certification in their briefs, we instructed them to discuss at oral argument the propriety of certifying the question of O.R.C. § 2919.123’s scope and meaning to the Supreme Court of Ohio. When asked about certification at oral argument, both Planned Parenthood and the State encouraged this court to speculate on how the Supreme Court of Ohio would interpret the statute as opposed to seeking an authoritative interpretation from the Ohio high court via certification. In our opinion, however, the interests of judicial federalism and comity strongly counsel in favor of providing the Supreme Court of Ohio with the opportunity to interpret O.R.C. § 2919.123. Accordingly, we
sua sponte
CERTIFY the questions set forth in § II, B of this order to the Supreme Court of Ohio pursuant to Rule XVIII of the Rules of Practice of the Supreme Court of Ohio.
See generally Elkins v. Moreno,
I. BACKGROUND
A. Factual History
This court’s previous opinion set forth the relevant facts as follows:
Until 2000, most first trimester abortions in this country were surgical abortions performed by vacuum aspiration or curettage. In September of 2000, the Food and Drug Administration (“FDA”) approved mifepristone [commonly referred to as RU-486], a pill used to induce an abortion without surgical intervention, for manufacture and use in the United States. This approval was based on clinical trials which involved the oral ingestion of 600 mg of mifepristone followed two days later by the oral ingestion of 0.4 mg of misoprostol. 2
Absent state regulation, once a drug has been approved by the FDA, doctors may prescribe it for indications and in dosages other than those expressly approved by the FDA. This is a widely employed practice known as “off-label” •use. Off-label use does not violate federal law or FDA regulations because the FDA regulates the marketing and distribution of drugs in the United States, not the practice of medicine, which is the exclusive realm of individual states. As a result of this research, an off-label protocol was developed consisting of 200 mg of mifepristone administered orally followed one to three days later by 0.8 mg of misoprostol administered vaginally. This regimen is employed up to sixty-three days’ gestation and is known as the Schaff protocol after the doctor whose research primarily led to its development.
In 2004, the Ohio General Assembly enacted H.B. 126 (“the Act”) to regulate the use of mifepristone in Ohio. Specifically, the Act provides:
No person shall knowingly give, sell, dispense, administer, otherwise provide, or prescribe RU-486 (mifepri-stone) to another for the purpose of inducing an abortion ... unless the person ... is a physician, the physician satisfies all the criteria established by federal law that a physician must satisfy in order to provide RU- *409 486 (mifepristone) for inducing abortions, and the physician provides the RU-486 (mifepristone) to the other person for the purpose of inducing an abortion in accordance with all provisions of federal law that govern the use of RU-486 (mifepristone) for inducing abortions.
Ohio Rev.Code Ann. § 2919.128(A). The Act defines “federal law” as, “any law, rule, or regulation of the United States or any drug approval letter of the food and drug administration of the United States that governs or regulates the use of RU-486 (mifepristone) for the purpose of inducing abortions.” Ohio Rev.Code Ann. § 2919.123(F). This arguably requires doctors who prescribe mifepristone for the purpose of inducing an abortion to do so only in accordance with the indication, regimen and distribution restrictions approved by the FDA. In other words, the Act arguably prohibits the “off-label” use of mifepri-stone.
According to the State, the Act was passed because abortion providers in Ohio were openly using the Schaff protocol and “because legislators became aware that several women had died or been severely injured recently as a result of their use of mifepristone.” The State further suggests that Ohio legislators concluded that the FDA had only approved one specific protocol for the administration of mifepristone because that was the only safe and effective protocol. Accordingly, the State argues that [it] banned all other uses of mifepri-stone to protect Ohio women from unsafe and ineffective mifepristone protocols.
Taft,
While Planned Parenthood previously instructed its doctors that mifepristone could be administered up to sixty-three days’ gestation, its instructions now provide that mifepristone only be administered up to fifty-six days’ gestation. Thus, there can be no debate that physicians in Ohio continue to administer mifepristone beyond the FDA-approved use of forty-nine days’ gestation. These doctors also continue to perform medical abortions using doses of mifepristone that are lower than those approved by the FDA.
B. Procedural History
Section 2919.123 was scheduled to go into effect on September 23, 2004. But, prior to the effective date, Planned Parenthood filed a complaint in United States District Court for the Southern District of Ohio alleging that the statute: (1) is void for vagueness; (2) violates a woman’s constitutional right to bodily integrity by forcing her to undergo a surgical abortion where a medical abortion using mifepri-stone would be more desirable; (3) lacks the constitutionally-mandated exception for the life and health of the woman; and (4) imposes an undue burden on a woman’s right to an abortion in violation of Supreme Court precedent. On September 22, 2004, the district court issued a preliminary injunction against the State’s enforcement of O.R.C. § 2919.123.
See Planned Parenthood v. Taft,
On appeal, we held that the district court erroneously determined that every abortion statute must contain an exception for the life or health of the woman.
Taft,
On remand, Planned Parenthood moved for summary judgment and sought a permanent injunction on the basis that O.R.C. § 2919.123 is unconstitutionally vague. Agreeing with Planned Parenthood, the district court declared the statute void for vagueness and permanently enjoined the entire statute’s enforcement.
Planned Parenthood v. Taft,
II. DISCUSSION
A. The Propriety of Certification
Rule XVIII of the Rules of Practice of the Supreme Court of Ohio provides the Supreme Court of Ohio with discretion to answer questions of Ohio law certified to it by the federal courts. As a prerequisite to certifying a question, we must determine that “there is a question of Ohio law that may be determinative of the proceeding and for which there is no controlling precedent.” R. of Prac. Sup.Ct. Ohio XVIII, § 1. In an opinion exhorting the values of federal court certification where resolution of a question of Ohio law is unclear, the Supreme Court of Ohio has explained that “state[ ] sovereignty is unquestionably implicated when federal courts construe state law.”
Scott v. Bank One Trust Co., N.A.,
Where statutory interpretation is at issue, the United States Supreme Court has instructed the federal courts to employ certification or abstention if the “uncon-strued state statute is susceptible of a
*411
construction by the state judiciary which might avoid in whole or in part the necessity for federal constitutional adjudication, or at least materially change the nature of the problem.”
Bellotti v. Baird,
Like the Massachusetts abortion statute involved in
Bellotti,
at the heart of this appeal is the interpretation of a novel and previously uninterpreted state statute. To resolve the issues presented in this case, we must ascertain what O.R.C. § 2919.123 means when it states that physicians who perform abortions using mifepristone must comply with “federal law,” as that term is defined in the statute.
See generally Kansas Judicial Review v. Stout,
Conversely, Planned Parenthood argues that the statute imposes no restrictions on the prescribing practices of physicians; it reads O.R.C. § 2919.123 to require only that physicians who prescribe mifepristone comply with the eight Subpart H requirements set forth in the approval letter because those are the only “requirements” in the letter that refer to physicians. Planned Parenthood further argues that, by its terms, O.R.C. § 2919.123 does not incorporate the treatment protocol set forth in the drug’s final printed labeling.
Planned Parenthood concedes that if its interpretation is adopted, then its claims that the statute is unconstitutional will be rendered moot. However, Planned Parenthood asserts that if the statute is interpreted to mean what the State says it means, then the statute is unconstitutional and was correctly enjoined by the district court. Under the provisions of Rule XVIII and precedent from the United States Supreme Court, certification is appropriate here because the manner in which O.R.C. § 2919.123 is interpreted “may be determinative of the proceeding,” R. Prac. Sup.Ct. Ohio XVIII, § 1, and “might avoid in whole or in part the necessity for federal constitutional adjudication.”
Bellotti,
While certainly we are capable of speculating on how the Supreme Court of Ohio would interpret O.R.C. § 2919.123, such “[s]peculation by a federal court about the meaning of a state statute in the absence of prior state court adjudication is particularly gratuitous when ... the state courts stand willing to address questions of state
*412
law on certification.”
Arizonans for Official English,
B. The Certified Questions of State Law
For the reasons set forth above, we certify the following questions of state law to the Supreme Court of Ohio pursuant to Rule XVIII of the Rules of Practice of the Supreme Court of Ohio:
1) Does O.R.C. § 2919.123 mandate that physicians in Ohio who perform abortions using mifepristone do so in compliance with the forty-nine-day gestational limit described in the FDA approval letter?
2) Does O.R.C. § 2919.123 mandate that physicians in Ohio who perform abortions using mifepristone do so in compliance with the treatment protocols and dosage indications described in the drug’s final printed labeling?
C. The Information Required by Rule XVIII
Because this court is certifying questions to the Supreme Court of Ohio, we provide the following information in accord with Rule XVIII, § 2(A)-(E).
1. Name of the case: Please refer to the caption on page 1 of this order.
2. Statement of facts: Please refer to § I of this order for a full recitation of the pertinent facts.
3. Name of each of the parties:
a. Plaintiffs-Appellees: Planned Parenthood Cincinnati Region; Planned Parenthood of Greater Cleveland; Planned Parenthood of Central Ohio; Preterm; Dr. Roslyn Kade; and Dr. Laszlo Sogor.
b. Defendants-Appellants: Nancy H. Rogers, Interim Ohio Attorney General, in her official capacity; Joseph T. Deters as Prosecuting Attorney for Hamilton County, Ohio, and as a representative of a class of all Prosecuting Attorneys in Ohio.
4. Names, Addresses, and Telephone Numbers of Counsel for Each Party:
a. Plaintiffs-Appellees’ Counsel:
Ms. Mimi Y.C. Liu Ms. Nicole G. Berner Planned Parenthood Federation of America 1780 Massachusetts Ave., N.W. Washington, D.C. 20036 (202) 973-4862
Mr. Roger K. Evans Planned Parenthood Federation of America 434 W. 33rd St. New York, N.Y. 10001-0000
Mr. Jeffrey M. Gamso American Civil Liberties Union of Ohio Foundation 4506 Chester Ave. Max Wohl Civil Liberties Center Cleveland, OH 44103-2136 (216) 472-2220
Ms. B. Jessie Hill Case Western Reserve University School of Law 11075 East Boulevard Cleveland, OH 44106-0000 *413 (212) 541-7800
Ms. Jennifer L. Branch Mr. Alphonse A. Gerhardstein Gerhardstein & Branch 617 Vine St. Suite 1409 Enquirer Building Cincinnati, OH 45202-0000 (513) 621-9100 (216) 368-0553
b. Defendants-Appellants’ Counsel:
Ms. Anne Berry Strait Office of the Attorney General Court of Claims Defense Section 150 E. Gay St. 23rd Floor Columbus, OH 43215 (614) 466-7447
Ms. Sharon A. Jennings Office of the Attorney General 30 E. Broad St. 15th Floor State Office Tower Columbus, OH 43215 (614) 466-2872
Ms. Holly J. Hunt Office of the Attorney General Constitutional Offices Section 30 E. Broad St. 17th Floor Columbus, OH 43215 (614) 466-2872
Mr. Roger Friedmann Assistant Prosecuting Attorney Hamilton County, Ohio 230 E. Ninth St. Suite 4000 Cincinnati, OH 45202 (513) 946-3025
Mr. Michael G. Florez Assistant Prosecuting Attorney Hamilton County, Ohio 230 E. Ninth St., Suite 4000 Cincinnati, OH 45202 (513) 946-3229
5. Designation of Moving Party: Although neither side has sought certification, we designate Interim Ohio Attorney General, Nancy H. Rogers, and Hamilton County, Ohio, Prosecuting Attorney, Joseph T. Deters, as representative for a class of all Ohio prosecuting attorneys— who have been collectively referred to throughout this order as the “State”-as the moving parties.
D. Instructions to the Clerk
In accordance with Rule XVIII, § 3 of the Rules of Practice of the Supreme Court of Ohio, Mr. Leonard Green, Clerk of the United States Court of Appeals for the Sixth Circuit, is hereby instructed to serve copies of this certification order upon counsel for the parties and to file this certification order under the seal of this court with the Supreme Court of Ohio, along with appropriate proof of service.
III. CONCLUSION
For the foregoing reasons, we CERTIFY questions of state law to the Supreme Court of Ohio. It is further ordered that *414 the district court’s injunction against the enforcement of O.R.C. § 2919.123 remain in full force and effect pending further order of this court.
Notes
. Ohio Governor Ted Strickland initially succeeded his predecessor, Bob Taft, as a defendant-appellant in this action. Subsequent to the filing of this appeal, however, Governor Strickland was granted permission to withdraw as an appellant.
. The mifepristone is an abortifacienl which terminates the pregnancy by detaching the gestational sac from the uterine wall. The misoprostol is a prostaglandin which induces the contractions necessary to expel the fetus and other products of conception from the uterus.
